Pfizer swallows tough pill, withdraws from AstraZeneca deal; Staples misses goals, awards bonuses anyway; Cinnabon's key ingredient (Video)
May 27, 2014 at 07:41 AM EDT
Pharmaceutical giant Pfizer has stepped back from a potential $119 billion deal with AstraZeneca, and since Pfizer (NYSE: PFE) said it would not attempt a hostile takeover, that puts the courtship on hold for the foreseeable future...